関連する実験動画
Updated: Sep 8, 2025

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
498
サルコペニアが小児クローン病の臨床結果に与える影響
Giulia D'Arcangelo1,2, Delia De Mitri1, Ludovica Busato3
1Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Rome, Italy.
Inflammatory bowel diseases
|September 5, 2025
まとめ
サルコペニア,または筋肉質の低下は,診断時にクローン病 (CD) の子供の臨床再発のリスクを高めます. MRIによる早期発見は 最悪の結果を予測するのに役立ちます
科学分野:
- 小児胃腸内科
- 炎症性腸疾患の研究
- 臨床的栄養と身体構成
背景:
- 子どものクローン病 (Crohn's disease,CD) の臨床結果に対するサルコペニアの影響は,ほとんど未調査のままである.
- 早期の病気の進行を予測する要因を理解することは,小児CDの適切な介入に不可欠です.
研究 の 目的:
- 診断時のサルコペニアと小児CD患者の臨床結果との関連を調査する.
- サルコペニアが再発,入院,合併症,治療のエスカレーションを 予測するかどうかを判断する.
主な方法:
- 新規診断の小児CD患者 (2011年−2022年) の遡及症例対照研究
- L3-L4のMRIでpsoas筋肉領域 (tPMA) を介して評価されたサルコペニアは,z-スコア ≤2SDsとして定義されています.
- サルコペニアと非サルコペニアの2年間のアウトカム (再発,入院,合併症,治療変更) の比較
主要な成果:
- サルコペニアは,対象となった78人の子供の59%に存在した.
- サルコペニアの患者は,臨床再発のリスクが6ヶ月と12ヶ月で有意に高かった (ORはそれぞれ7. 5と6. 5).
- サルコペニアは独立して臨床再発 (OR1. 7) を予測し,サルコペニアの子供では再発のない生存率が低いことが観察されました.
結論:
- 診断時のサルコペニアは,小児クローン病の臨床再発の重要な危険因子です.
- 全体のpsoas筋肉領域 (tPMA) のMRIベースの評価は,有害な結果のリスクが高いCDを特定することができます.
- サルコペニアの早期発見は,小児CDの積極的な管理戦略を導くことができます.
関連する概念動画
Inflammatory Bowel Disease II: Crohn's Disease
370
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
370
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
407
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
407
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
200
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
200
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
Esophageal Strictures-II: Clinical Features and Management
155
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
155
Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K

